Kyverna Therapeutics

1 open job

General information

Kyverna Therapeutics is a late-stage clinical biopharmaceutical company founded in 2018. It develops CD19-targeting CAR T-cell therapy for severe autoimmune diseases driven by B cells. Its lead candidate, miv-cel, is in a rolling Biologics License Application submission for stiff person syndrome.

Gilead Sciences has been a strategic partner since January 2020, when it paid $17.5 million upfront as part of a collaboration deal. That backing supports Kyverna's work as it moves candidates through late-stage development. Kyverna Therapeutics is an H-1B sponsor.1

Headquarters
United States
Industry
Healthcare & Life Sci
Category
Pharma & Biotech
Employees
55
Visa sponsor
Yes

Week by week at Kyverna Therapeutics

New listings added per week

Window
Day 21 of 60. Velocity views unlock around December 5, 2026.Day 21 of 60. Opens with the chart.Opens about a month after the chart unlocks.Tracking since Sep 2026. A 365-day window opens in September 2027.

Chart withheld

insufficient history

Not enough history yet

Tracking since September 16, 2026 · day 21 of 60

Velocity stats appear after 60 days of clean history. We're on day 21.

A weekly-adds chart drawn from that window would mostly show the day we started looking, not how Kyverna Therapeutics hires. Every window control above is disabled, and each one says when it opens.

How the pipeline collects listings →

Roles added per week

Not yet available

suppressed until 60 days of clean history

Busiest week in this window

Not yet available

suppressed with the chart

Tracked by InterviewOS since

September 2026

Days of clean history

21 / 60

velocity stats unlock at 60 days

Open roles right now

1

Open jobs

1 open · updated today

Page 1 of 1, most recently added first · Download (CSV)2

Want to know which of these 1 jobs are worth your time? Upload your CV and we'll score how well you match each one before you apply. It's free.

Score your CV for free before you apply

Visa sponsorship

Does Kyverna Therapeutics sponsor visas? Using USCIS data, we've collected the number of H-1Bs granted from 2021 to 2023 as well as the number of petitions they've requested so far this year. Kyverna Therapeutics is a likely employer for applicants who require sponsorship. Currently, they have 2 jobs certified for sponsorship in 2026, at a median pay of $195,500.3

Visa petitions approved each year (USCIS)3

H1B petitions approved, by fiscal year (USCIS)
Fiscal yearApproved
FY20211
FY20220
FY20230

Based on public USCIS and Department of Labor records. Past filings do not guarantee future sponsorship. Browse all H1B sponsors →

Similar companies

Browse all companies hiring now →

Common questions

Is Kyverna Therapeutics hiring now?

Yes. There are 1 open jobs.

Does Kyverna Therapeutics sponsor H-1B visas?

Yes. Government records show 2 jobs certified for FY2026, at a median pay of $195,500.

Interview OS

Company pages built from direct checks of real hiring systems.

Create free account

Notes & sources

19 daily listing observations, Sep 16 to Oct 31 windowRechecked daily, last October 31, 2026
  1. 1. Company description. Written by InterviewOS from Kyverna Therapeutics's public materials and press coverage; facts are checked against the sources below.
  2. 2. Live counts. Deduplicated live listings observed daily on Kyverna Therapeutics's own hiring system; last check October 31, 2026. Stale and syndicated posts on aggregator sites are not counted.
  3. 3. Federal visa records. USCIS H1B Employer Data Hub and US Department of Labor LCA disclosure files, matched to this company by name.

Sources
USCIS H-1B Employer Data Hub
US Department of Labor LCA disclosure files
About the data
Report a data issue with this page